Pharming Group NV (NASDAQ:PHAR)

Delayed Data
As of Sep 20
 0.00 / 0.00%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Pharming Group NV have a median target of 21.38, with a high estimate of 40.00 and a low estimate of 17.51. The median estimate represents a +43.10% increase from the last price of 14.94.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Pharming Group NV. This rating has held steady since September, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Oct 26

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -800.00%
Growthannually -98.68%


Growthquarterly 9.07%
Growthannually 12.39%
Key to the earnings and sales forecast charts.